Mumbai: Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Ltd. announced its successful completion joint venture (JV) – Bayer Zydus Pharma Private Limited (BZPPL).

The 50:50 joint venture was set up on January 28, 2011 for sales and marketing. pharmaceutical products in India. As per the pre-agreed joint venture terms, Bayer is now securing full ownership of the unit.

The joint venture successfully leveraged the strengths of both companies to better serve the rapidly growing Indian market. It combines Zydus’ strong Indian marketing, sales expertise, wide distribution reach and rich industry network with Bayer’s global expertise in commercializing new products and bringing innovation to India.

Commenting on the closing of the joint venture, Shweta Rai, Managing Director – India and Country Division Head – South Asia, Pharmaceuticals Division of Bayer, said, “Zydus Lifesciences is a strong addition to our joint mission towards introducing best-in-class innovative Has been a partner. health solutions and addressing the unmet health care needs of patients in India. As we assume full ownership of BZPPL, Bayer is committed to ensuring its strong presence in India. Building on the achievements made over more than a decade, we aim to carry forward our mission of ‘Health for All, Hunger for None’.